(CDX) Simplify Exchange Traded - Ratings and Ratios
High-Yield Bond, ETF, Derivatives, Credit-Hedge
Description: CDX Simplify Exchange Traded October 29, 2025
The Simplify High-Yield Bond ETF (NYSE ARCA: CDX) aims to generate returns by allocating at least 80% of its net assets to high-yield (junk) bonds, primarily through other exchange-traded funds, while employing up to 20% of its portfolio in credit-hedge derivatives to manage downside risk.
As of Q3 2025, CDX carries an expense ratio of 0.45% and manages roughly $1.2 billion in assets; the high-yield spread over U.S. Treasuries is hovering near 5.8%, and corporate default rates in the sector have risen to about 3.2% year-to-date, reflecting a tightening monetary environment that can amplify both yield opportunities and credit risk.
If you want a deeper quantitative view of how CDX’s credit-hedge strategy performs across different market regimes, checking the ValueRay platform’s back-tested risk-adjusted metrics could be a useful next step.
CDX ETF Overview
| Market Cap in USD | 405m |
| Category | High Yield Bond |
| TER | 0.26% |
| IPO / Inception | 2022-02-14 |
CDX ETF Ratings
| Growth Rating | 81.3% |
| Fundamental | - |
| Dividend Rating | 87.6% |
| Return 12m vs S&P 500 | -9.64% |
| Analyst Rating | - |
CDX Dividends
| Dividend Yield 12m | 10.36% |
| Yield on Cost 5y | 12.71% |
| Annual Growth 5y | 30.78% |
| Payout Consistency | 92.7% |
| Payout Ratio | % |
CDX Growth Ratios
| Growth Correlation 3m | 34.3% |
| Growth Correlation 12m | 94.7% |
| Growth Correlation 5y | 92% |
| CAGR 5y | 11.17% |
| CAGR/Max DD 3y (Calmar Ratio) | 1.26 |
| CAGR/Mean DD 3y (Pain Ratio) | 6.37 |
| Sharpe Ratio 12m | 0.41 |
| Alpha | -4.51 |
| Beta | 0.640 |
| Volatility | 5.84% |
| Current Volume | 149.4k |
| Average Volume 20d | 175.5k |
| Stop Loss | 21.9 (-3.4%) |
| Signal | -0.14 |
What is the price of CDX shares?
Over the past week, the price has changed by -0.57%, over one month by -0.48%, over three months by -0.47% and over the past year by +9.48%.
Is Simplify Exchange Traded a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CDX is around 24.71 USD . This means that CDX is currently overvalued and has a potential downside of 9.05%.
Is CDX a buy, sell or hold?
What are the forecasts/targets for the CDX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 27.5 | 21.4% |
CDX Fundamental Data Overview October 20, 2025
Beta = 0.64
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 404.9m USD (404.9m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 404.9m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 404.9m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.37% (E(404.9m)/V(404.9m) * Re(8.37%) + (debt-free company))
Discount Rate = 8.37% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for CDX ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle